| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/03/2009 | US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells |
| 12/03/2009 | US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 12/03/2009 | US20090298800 1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof |
| 12/03/2009 | US20090298792 Anti-Inflammatory Polymer |
| 12/03/2009 | US20090298744 Heterocyclic compounds as adenosine receptor antagonist |
| 12/03/2009 | US20090297624 Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans |
| 12/03/2009 | US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 12/03/2009 | US20090297614 Nanoparticles for providing immune responses against infectious agents |
| 12/03/2009 | US20090297598 Therapeutic combination |
| 12/03/2009 | US20090297590 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
| 12/03/2009 | US20090297559 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 12/03/2009 | US20090297558 Inactivated Influenza Virus Compositions |
| 12/03/2009 | US20090297551 Adjuvant |
| 12/03/2009 | US20090297548 Immunogenic compositions comprising anthrax spore-associated proteins |
| 12/03/2009 | US20090297545 Immunomodulatory dairy peptides and uses thereof |
| 12/03/2009 | US20090297541 Maturation of dendritic cells |
| 12/03/2009 | US20090297540 Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof |
| 12/03/2009 | US20090297524 Compositions monovalent for CD40L binding and methods of use |
| 12/03/2009 | US20090297518 Immunopotentiative composition |
| 12/03/2009 | US20090297510 Inhibition of calpain reduces allergic inflammation |
| 12/03/2009 | US20090297504 Bcma polypeptides and uses thereof |
| 12/03/2009 | US20090297478 Methods and Compositions for the Treatment of Lupus Using Clofarabine |
| 12/03/2009 | CA2762314A1 Mechanism of action of primary cell derived biologic |
| 12/03/2009 | CA2726247A1 Method and means for treating viral disease, in particular hiv/aids |
| 12/03/2009 | CA2725637A1 Methods of treating inflammatory colon diseases |
| 12/03/2009 | CA2725545A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 12/03/2009 | CA2725051A1 Probiotics to improve gut microbiota |
| 12/03/2009 | CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/03/2009 | CA2721061A1 Treatment of thromboangiitis obliterans by removal of autoantibodies |
| 12/03/2009 | CA2710040A1 A soluble tumor necrosis factor receptor mutant |
| 12/02/2009 | EP2128248A1 Oligonucleotide compositions with enhanced efficiency |
| 12/02/2009 | EP2127670A1 Liposome for induction of cell-mediated immunity |
| 12/02/2009 | EP2127666A1 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 12/02/2009 | EP2127662A1 Rankl production inhibitor |
| 12/02/2009 | EP2127661A1 Probiotics to improve gut microbiotica |
| 12/02/2009 | EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
| 12/02/2009 | EP2125895A2 Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis |
| 12/02/2009 | EP2125891A2 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 12/02/2009 | EP2125817A1 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/02/2009 | EP2125804A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoý4,5-b¨pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 12/02/2009 | EP2125797A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 12/02/2009 | EP2125738A1 Immune response modifier compositions and methods |
| 12/02/2009 | EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 12/02/2009 | EP2125725A1 Compounds of formula (i) as serine protease inhibitors |
| 12/02/2009 | EP2125500A2 Hiv combination vaccine and prime boost method |
| 12/02/2009 | EP2124994A2 Soluble fc gamma r1a for reducing inflammation |
| 12/02/2009 | EP2124988A2 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 12/02/2009 | EP2124888A2 Sustained delivery formulations of rapamycin compounds |
| 12/02/2009 | EP1902046B1 Piperidine derivatives useful as histamine h3 antagonists |
| 12/02/2009 | EP1896453B1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 12/02/2009 | EP1863785B1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 12/02/2009 | EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 12/02/2009 | EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor |
| 12/02/2009 | EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
| 12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 12/02/2009 | EP1248804B2 Recombinant antibodies to human interleukin-1 beta |
| 12/02/2009 | CN101595213A Cancerous disease modifying antibodies |
| 12/02/2009 | CN101595110A 7-substituted purine derivatives for immunosuppression |
| 12/02/2009 | CN101591397A Recombinant expression and application of long-acting thymosin alpha1 |
| 12/02/2009 | CN101591337A Compound formed by splicing ferulic acid and matrine compound and application thereof |
| 12/02/2009 | CN101591228A Novel azulene compounds and application thereof |
| 12/02/2009 | CN101590223A SOD complex capsule and preparation method thereof |
| 12/02/2009 | CN101590222A SOD cell repair liquid and preparation method thereof |
| 12/02/2009 | CN101590114A Medicament for treating multiple sclerosis and preparation method thereof |
| 12/02/2009 | CN101590105A Chinese medicinal herb extract for inducing immune cells to generate interferon and activated TOLL-like receptors and preparation method thereof |
| 12/02/2009 | CN101590097A Chinese herbal medicine prescription for reducing blood pressure and blood fat and improving sleep |
| 12/02/2009 | CN101590070A Use of baicalin in preparation of targeted organ protection medicaments |
| 12/02/2009 | CN101590050A Medicine for treating allergic rhinitis and preparation method thereof |
| 12/02/2009 | CN101590015A Cationic adhesion type mycophenolate mofetil nano eye drop |
| 12/02/2009 | CN101590010A Mycophenolate mofetil intraocular medicament releasing system |
| 12/02/2009 | CN101589801A Process for manufacturing red ginseng honey slice |
| 12/02/2009 | CN100564511C Composition having immunoregulating activities |
| 12/02/2009 | CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 12/02/2009 | CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof |
| 12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 12/02/2009 | CN100563709C Novel targeted tissue factor antibody as anticoagulants |
| 12/02/2009 | CN100563707C Activation and inhibition of the immune system |
| 12/02/2009 | CN100563697C Rhodiola rosea hippophae rhamnoides tablet and method of preparing the same |
| 12/02/2009 | CN100563671C Fox immunity enhancer |
| 12/02/2009 | CN100563654C Desloratadine dispersible tablet and its preparation method |
| 12/01/2009 | US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design |
| 12/01/2009 | US7626042 O-substituted hydroxyaryl derivatives |
| 12/01/2009 | US7625999 Immobilization on solid support |
| 12/01/2009 | US7625950 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 12/01/2009 | US7625934 Metalloproteinase inhibitors |
| 12/01/2009 | US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 12/01/2009 | US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia |
| 12/01/2009 | US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/01/2009 | US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 12/01/2009 | US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections |
| 12/01/2009 | US7625879 Phosphohalohydrins, process for the production thereof and use thereof |
| 12/01/2009 | US7625872 a branch-point nucleoside to which three core nucleic acid moieties are covalently coupled; therapy for cancer and Th2-type immune response (e.g., an allergy or allergy-induced asthma) by increasing the secretion of interferon-gamma |
| 12/01/2009 | US7625861 Copolymer-1 improvements in compositions of copolymers |
| 12/01/2009 | US7625752 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential |
| 12/01/2009 | US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/01/2009 | US7625573 Immunology active materials; anticancer agents, infections, autoimmune diseases, parasiticides; lipid bilayer with antitumor agent |